Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of innovative technologies for chimeric antigen receptor T-cell (CAR T) therapies... Show more
Industry Biotechnology
A.I.dvisor indicates that over the last year, CLYYF has been loosely correlated with ELVAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYYF jumps, then ELVAF could also see price increases.
| Ticker / NAME | Correlation To CLYYF | 1D Price Change % | ||
|---|---|---|---|---|
| CLYYF | 100% | N/A | ||
| ELVAF - CLYYF | 47% Loosely correlated | N/A | ||
| WHWK - CLYYF | 37% Loosely correlated | -8.33% | ||
| HLVX - CLYYF | 26% Poorly correlated | N/A | ||
| REPL - CLYYF | 25% Poorly correlated | -1.04% | ||
| WXXWY - CLYYF | 25% Poorly correlated | -3.87% | ||
More | ||||